Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Winsor Health Products (also known as Integrated Chinese Medicine Holdings) is a biotechnology company specializing in the development and commercialization of medicinal mushroom extracts, most notably Polysaccharide Peptide (PSP) derived from the COV-1 strain of Coriolus versicolor. The company's products are based on the pioneering research of Professor Yang Qingyao, who developed proprietary deep-layer cultivation and extraction techniques for PSP. Their flagship product, I'm-Yunity, is used as an adjunct therapy in cancer treatment to boost immune function and improve quality of life for patients undergoing chemotherapy or radiotherapy. The company has a strong focus on clinical validation, with studies conducted at institutions such as the University of Pennsylvania and various hospitals in China. Winsor Health Products maintains manufacturing facilities in Shanghai and distribution headquarters in Hong Kong.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Professor Yang Qingyao.